search
Back to results

MY01 - An Aid for Diagnosing Acute Compartment Syndrome in Real Time

Primary Purpose

Acute Compartment Syndrome

Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
MY01 - Continuous Compartmental Pressure Monitor
Sponsored by
MY01 Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Acute Compartment Syndrome focused on measuring Acute Compartment Syndrome

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Men or women, aged 18 years of age and older
  • Any tibial, foot, femoral, forearm or fracture that is felt by the surgeon to have a reasonable indication that elevated ICP could occur in the patient
  • Mentally fit to provide informed consent

Exclusion Criteria:

  • Patients with fractures that are not felt to be at risk of developing compartment syndrome based on serial clinical evaluation
  • Infected wounds; infected fractures
  • Patients who present with ACS requiring urgent surgical fasciotomy
  • Patients who cannot consent to trial
  • Pregnant women

Sites / Locations

  • Montreal General HospitalRecruiting
  • Hôpital du Sacré-Coeur de MontrealRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

MY01 Device

Arm Description

Insertion of the MY01 device for up to 24 hours for continuous monitoring of compartment pressure

Outcomes

Primary Outcome Measures

Clinical ease with which the new compartment pressure monitor was inserted into compartment.
At device insertion, the physician will complete a feedback questionnaire, and routine assessment will be performed in compliance with the standard of care. As part of the feedback questionnaire, the physician will be asked to indicate on a sliding scale "How certain are you the device functioned adequately?" [0 = not confident] - [10 = very confident]. The scale, administered part of a Clinical Report Form (CRF) titled 'Physician Survey', measures the physicians subjective level of certainty that the device sensor was inserted correctly within a patients muscle compartment. A record of 10 should be considered a very positive scenario, whereas a record of 0 should indicate a very negative scenario.
Ability to monitor in real-time the continuous pressure read-out from the compartment in remote locations such as an I-phone.
At device insertion, the physician will complete a feedback questionnaire, and routine assessment will be performed in compliance with the standard of care. As part of the feedback questionnaire, the physician will be asked to indicate in a Yes or No question "Did the MY01 Application remote data display work properly?" [Yes] or [No].
The correlation of continuous pressure read-outs (high, normal or low) with clinical indications for compartment syndrome in each patient.
Routine assessments will be completed by healthcare personnel as per standard of care (the 6P's [Pain, Paraesthesia, Pallor, Paralysis, Pulselessness, Poikilothermia]), and compared against the pressure readout [mmHG] indicated by MY01's MicroElectroMechanical (MEMS) pressure sensor inserted at the afflicted location.

Secondary Outcome Measures

Correlation of clinical compartment syndrome release with data from the continuous pressure monitor read-out.
Should surgical fasciotomy be deemed necessary to release pent up pressure in the patients muscle compartment, the continuous pressure read-outs [mmHG] derived from the device will be compared against the timeframe when the decision to conduct fasciotomy was made.
Short-term outcomes of the patient following continuous pressure monitoring
Survey and tabulation of data from patient clinical findings.

Full Information

First Posted
July 3, 2019
Last Updated
August 11, 2021
Sponsor
MY01 Inc.
Collaborators
McGill University Health Centre/Research Institute of the McGill University Health Centre, Hopital du Sacre-Coeur de Montreal
search

1. Study Identification

Unique Protocol Identification Number
NCT04016103
Brief Title
MY01 - An Aid for Diagnosing Acute Compartment Syndrome in Real Time
Official Title
MY01 - An Aid for Diagnosing Acute Compartment Syndrome in Real Time
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Unknown status
Study Start Date
July 17, 2020 (Actual)
Primary Completion Date
December 2021 (Anticipated)
Study Completion Date
December 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
MY01 Inc.
Collaborators
McGill University Health Centre/Research Institute of the McGill University Health Centre, Hopital du Sacre-Coeur de Montreal

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Compartment syndrome can result from extremity trauma. It can also be caused by procedural cases that involve lower or upper extremity surgery. This condition results in muscle death, chronic pain, infection, and possible amputation. Early diagnosis is essential to institute interventions that can avoid complications. Subjective pain of the patient remains the mainstay for diagnosis. A method or device is needed that would improve our accuracy in diagnosing compartment syndrome. Ideally, this would be suited for single and/or continuous pressure read-outs. The aim is to reduce the incidence of missed compartment syndrome and diminish delays that would lead to significant disability. Despite awareness, delayed diagnosis and treatment occurs in modern orthopaedic practice. As noted in many studies, once a diagnosis has been made, immediate fasciotomy is necessary to provide the best chance for a favourable clinical result. Therefore, there is a need for improved devices in order to obtain an early and reliable diagnosis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Compartment Syndrome
Keywords
Acute Compartment Syndrome

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
MY01 Device
Arm Type
Experimental
Arm Description
Insertion of the MY01 device for up to 24 hours for continuous monitoring of compartment pressure
Intervention Type
Device
Intervention Name(s)
MY01 - Continuous Compartmental Pressure Monitor
Intervention Description
Insertion of the MY01 device for up to 24 hours for continuous monitoring of compartment pressure
Primary Outcome Measure Information:
Title
Clinical ease with which the new compartment pressure monitor was inserted into compartment.
Description
At device insertion, the physician will complete a feedback questionnaire, and routine assessment will be performed in compliance with the standard of care. As part of the feedback questionnaire, the physician will be asked to indicate on a sliding scale "How certain are you the device functioned adequately?" [0 = not confident] - [10 = very confident]. The scale, administered part of a Clinical Report Form (CRF) titled 'Physician Survey', measures the physicians subjective level of certainty that the device sensor was inserted correctly within a patients muscle compartment. A record of 10 should be considered a very positive scenario, whereas a record of 0 should indicate a very negative scenario.
Time Frame
24-48 hours following device insertion
Title
Ability to monitor in real-time the continuous pressure read-out from the compartment in remote locations such as an I-phone.
Description
At device insertion, the physician will complete a feedback questionnaire, and routine assessment will be performed in compliance with the standard of care. As part of the feedback questionnaire, the physician will be asked to indicate in a Yes or No question "Did the MY01 Application remote data display work properly?" [Yes] or [No].
Time Frame
24-48 hours following device insertion
Title
The correlation of continuous pressure read-outs (high, normal or low) with clinical indications for compartment syndrome in each patient.
Description
Routine assessments will be completed by healthcare personnel as per standard of care (the 6P's [Pain, Paraesthesia, Pallor, Paralysis, Pulselessness, Poikilothermia]), and compared against the pressure readout [mmHG] indicated by MY01's MicroElectroMechanical (MEMS) pressure sensor inserted at the afflicted location.
Time Frame
24-48 hours following device insertion, and again during the final follow-up of the participant approximately two weeks after treatment
Secondary Outcome Measure Information:
Title
Correlation of clinical compartment syndrome release with data from the continuous pressure monitor read-out.
Description
Should surgical fasciotomy be deemed necessary to release pent up pressure in the patients muscle compartment, the continuous pressure read-outs [mmHG] derived from the device will be compared against the timeframe when the decision to conduct fasciotomy was made.
Time Frame
24-48 hours following device insertion, and again during the final follow-up of the participant approximately two weeks after treatment
Title
Short-term outcomes of the patient following continuous pressure monitoring
Description
Survey and tabulation of data from patient clinical findings.
Time Frame
24-48 hours following device insertion.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Men or women, aged 18 years of age and older Any tibial, foot, femoral, forearm or fracture that is felt by the surgeon to have a reasonable indication that elevated ICP could occur in the patient Mentally fit to provide informed consent Exclusion Criteria: Patients with fractures that are not felt to be at risk of developing compartment syndrome based on serial clinical evaluation Infected wounds; infected fractures Patients who present with ACS requiring urgent surgical fasciotomy Patients who cannot consent to trial Pregnant women
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Cooper Jefferson
Phone
7057902959
Email
cooper.jefferson@nxtsens.com
First Name & Middle Initial & Last Name or Official Title & Degree
Mary Amedeo
Phone
(514) 934-1934
Ext
43386
Email
mary.amedeo@muhc.mcgill.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mitchell Bernstein, MD
Organizational Affiliation
Staff Surgeon, Orthopaedic Trauma & Limb Deformity, Montreal General Hospital | Assistant Professor Department of Surgery and Pediatric Surgery McGill University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Montreal General Hospital
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H3G 1A4
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mary Amedo
Phone
(514) 934-1934
Ext
43386
Email
mary.amedeo@muhc.mcgill.ca
First Name & Middle Initial & Last Name & Degree
Dr. Mitchell Bernstein, MD
First Name & Middle Initial & Last Name & Degree
Dr. Rudolf Reindl, MD
First Name & Middle Initial & Last Name & Degree
Dr. Maxime Talbot, MD
Facility Name
Hôpital du Sacré-Coeur de Montreal
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H4J 1C5
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Karine Tardif
Phone
514-338-2222
Ext
3465
Email
karinetardif2@gmail.com
First Name & Middle Initial & Last Name & Degree
Julie Fournier
Phone
514-338-2222
Ext
514-338-2222
Email
fournier.julie77@gmail.com
First Name & Middle Initial & Last Name & Degree
Dr. Dominique Rouleau, MD
First Name & Middle Initial & Last Name & Degree
Dr. Yves Laflamme, MD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

MY01 - An Aid for Diagnosing Acute Compartment Syndrome in Real Time

We'll reach out to this number within 24 hrs